TFS Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,563
Closed -$335K 904
2017
Q1
$335K Sell
11,563
-9,617
-45% -$238K 0.11% 357
2016
Q4
$473K Buy
21,180
+2,741
+15% +$53.6K 0.13% 259
2016
Q3
$342K Sell
18,439
-21,864
-54% -$412K 0.08% 394
2016
Q2
$657K Sell
40,303
-92,207
-70% -$1.36M 0.12% 301
2016
Q1
$1.55M Buy
132,510
+115,555
+682% +$1.29M 0.22% 125
2015
Q4
$198K Sell
16,955
-663
-4% -$8.39K 0.02% 588
2015
Q3
$216K Buy
+17,618
New +$225K 0.02% 725
2015
Q2
Sell
-34,235
Closed -$303K 1278
2015
Q1
$303K Buy
34,235
+373
+1% +$3.77K 0.03% 670
2014
Q4
$340K Sell
33,862
-241,016
-88% -$2.07M 0.03% 695
2014
Q3
$1.84M Sell
274,878
-106,262
-28% -$745K 0.16% 196
2014
Q2
$2.73M Buy
381,140
+72,848
+24% +$580K 0.22% 123
2014
Q1
$3.11M Sell
308,292
-32,604
-10% -$300K 0.21% 131
2013
Q4
$2.71M Sell
340,896
-54,140
-14% -$505K 0.13% 231
2013
Q3
$3.92M Buy
395,036
+380,268
+2,575% +$2.99M 0.18% 145
2013
Q2
$87K Buy
+14,768
New +$49.7K ﹤0.01% 1435

Other funds holding BEAT

TFS Capital's BEAT Position: Q2 2017 in Review

TFS Capital sold out of BioTelemetry, Inc. (BEAT) in Q2 2017, closing a stake of 11,563 shares — an estimated $335K sold.

TFS Capital first reported a position in BEAT in Q2 2013 and held it in 15 quarters. The position peaked at $3.92M in Q3 2013. 195 funds tracked by Wall St. Rank hold BEAT as of Q2 2017.

  • TFS Capital reported no remaining BioTelemetry, Inc. position as of Q2 2017 after selling out during the quarter.
  • TFS Capital sold 11,563 BioTelemetry, Inc. shares in Q2 2017, an estimated $335K.
  • TFS Capital first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 15 quarters.
  • TFS Capital's BioTelemetry, Inc. position peaked at $3.92M in Q3 2013.
  • 195 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.